1,2,3,4,5,6-Hexa(prop-1-yn-1-yl)benzene, 98%, 100mg

1-(4-Methyl-1H-imidazol-2-yl)ethanone, 95.0%, 250mg

Ethyl 2-chloro-4-methylthiazole-5-carboxylate, 95.0%, 25g

5-(3-Methylphenyl)cyclohexane-1,3-dione, 97.0%, 1g

Bis(1,1-dimethylethyl)[4-methoxy-3,5,6-trimethyl-2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]phosphine, 98%, 100mg

3-Benzylrhodanine, 98.0%, 25g

3-Hydroxybenzaldehyde>98.0%(GC)(T)500g

2-AZASPIRO[4.4]NONANE-2-CARBOXYLIC ACID, 7-HYDROXY-, 1,1-DIMETHYLETHYL ESTER, 95.0%, 5g

Objetivo de antimonio 99,999% dia. 25,4 mm x espesor 6,35 mm 1 ud.

Ácido tolueno-4-sulfónico monohidrato, mínimo 98%, para síntesis, 500 g, envase de plástico.

1-(4-FORMYLPHENYL)-1-OXO-5,8,11,14-TETRAOXA-2-AZAHEPTADECAN-17-OIC ACID, 95%, 100mg

4-Nitrobenzenesulfonyl fluoride, 95.0%, 1g

3-Chloro-2-(3-(trifluoromethyl)-1H-pyrazol-1-yl)pyridine, 95%, 250mg